Our responsibility

For a sustainable development


Cantargia is a Swedish biotechnology company that specializes in the discovery and development of pharmaceuticals for treatment of cancer as well as inflammatory and autoimmune diseases. Our vision is to improve global health by contributing to the treatment of unmet medical needs for severe diseases and to improve the quality of life for these patients. To accomplish this, Cantargia is committed to discovering, developing and launching future products on the market in a sustainable way, taking Environmental, Social, and Governance (ESG) aspects into consideration.

Cantargia’s Board of Directors has adopted a Sustainability Policy. The policy outlines Cantargia’s commitment to minimizing our environmental impact, preserving resources, and contributing to a more sustainable future. Cantargia recognizes that all 17 of the United Nations Sustainable Development Goals (SDGs) are important, but our internal policy specifically aligns with and supports SDGs 3, 5, 8, 9, and 13. The policy further acknowledges the importance of and compliance with the European Union’s Corporate Sustainability Reporting Directive (CSRD).

Read our sustainability policy (PDF) here.

ESG Nasdaq